1Smeenk HG, Tran TC, Erdmann J, et al. Survival after surgical management of pancreatic adenocareinoma: does curative and radical surgery truly exist? [ J ]. Langenbecks Arch Surg,2005,390 (2) : 94 - 103.
2Crino L, Mosconi AM, Calandri C, et al. Gemcitabine in advanced pancreatic cancer: a phase Ⅱ trial[ J]. Am J Clin Oncol,2001,24 (3) :296 -298.
3Robertson JF, Watson SA, Hardcastle JD. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer [J]. lnt J Cancer, 1995, 63(1) :69 -75.
4Xiong HQ, Rosenberg A, LoBuglio A, et al. Cetuximab, a monoelonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase Ⅱ trial[J]. J Clin Oncol, 2004, 22(13):2610 - 2616.
5Graeven U, Kremer B, Sudhoff T, et al. Phase Ⅰ study of the humanized anti-EGFR monoclonal antibody matuzumab ( EMD 72000) combined with gemcitabine in advanced pancreatic cancer[ J]. Br J Cancer, 2006, 94(9):1293- 1299.
6Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer: A phase Ⅲ trial of the National Cancer Institute of Canada Clinical Trials Group [ J]. Proc Am Soc Clin Oncol,2005,25 ( 15 ) : 1960 - 1966.
7Iannitti D, Dipetfillo T, Akerman P, et al. Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase Ⅰ study[J]. Am J Clin Oneol,2005,28(6) :570 - 575.
8Rosetti M, Tesei A, Ulivi P, et al. Modulation of drug cytotoxicity by Iressa(ZD1839) in pancreatic cancer cell lines [ J ]. Cancer Bioi Ther, 2005, 4(10) :1089 - 1095.
9Czito BG, Willett CG, Bendell JC, et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase Ⅰ trial resuhs[J]. J Clin Oncol, 2006, 24(4) :656 - 662.
10Saxby AJ, Nielsen A, Scarlett CJ, et al. Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival[ J ]. Am J Surg Pathol, 2005, 29 (9) : 1125 - 1134.
